Bio-Techne Corp
Last updated September 27, 2026
Organization details
- Legal name
- Bio-Techne Corp
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- TECH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000842023
Board of directors
-
Alpna Seth · DirectorSince 2023
-
Amy E. Herr · DirectorSince 2025
-
Charles R. Kummeth · Director · Chief Executive OfficerSince 2023
-
John L. Higgins · DirectorSince 2023
-
Joseph D. Keegan · DirectorSince 2023
-
Judith Klimovsky V · DirectorSince 2024
-
Julie L. Bushman · DirectorSince 2023
-
Kim Kelderman · Director · Chief Executive OfficerSince 2024
-
Randolph C. Steer · DirectorSince 2023
-
Robert Baumgartner V · DirectorSince 2023
-
Roeland Nusse · DirectorSince 2023
-
Rupert Vessey · DirectorSince 2023
Chief executives
Kim Kelderman
· Chief Executive Officer
Dates unknown
Charles R. Kummeth
· Chief Executive Officer
Dates unknown
Board connections
6 of this board's directors also sit on 10 other boards.
- via Julie L. Bushman
- via Kim Kelderman
- via Alpna Seth
- via Rupert Vessey
- via Charles R. Kummeth
- via Alpna Seth
- via John L. Higgins
- via Charles R. Kummeth
- via Julie L. Bushman
- via Charles R. Kummeth
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $437,187
- 2 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Robert Baumgartner V Director | Option exercise | +15,940 | — | — |
| Sep 22, 2026 | Robert Baumgartner V Director | Shares withheld for tax | −5,559 | $72.55 | $403,305 |
| Aug 15, 2026 | Amy E. Herr Director | Option exercise | +589 | — | — |
| Aug 15, 2026 | Steven C. Crouse Officer (President - Diag & Spatial Bi) | Option exercise | +5,423 | — | — |
| Aug 15, 2026 | Bohnen Shane Officer (SVP - General Counsel) | Option exercise | +4,350 | — | — |
| Aug 15, 2026 | Geist William Officer (PRESIDENT, PROTEIN SCIENCES) | Option exercise | +6,416 | — | — |
| Aug 15, 2026 | Hippel James Officer (CFO) | Option exercise | +9,779 | — | — |
| Aug 15, 2026 | Kim Kelderman Director, Officer (Chief Executive Officer) | Option exercise | +21,470 | — | — |
| Aug 15, 2026 | Amy E. Herr Director | Shares withheld for tax | −213 | $72.40 | $15,421 |
| Aug 15, 2026 | Steven C. Crouse Officer (President - Diag & Spatial Bi) | Shares withheld for tax | −1,947 | $72.40 | $140,963 |
| Aug 15, 2026 | Bohnen Shane Officer (SVP - General Counsel) | Shares withheld for tax | −1,343 | $72.40 | $97,233 |
| Aug 15, 2026 | Geist William Officer (PRESIDENT, PROTEIN SCIENCES) | Shares withheld for tax | −1,976 | $72.40 | $143,062 |
| Aug 15, 2026 | Hippel James Officer (CFO) | Shares withheld for tax | −4,310 | $72.40 | $312,044 |
| Aug 15, 2026 | Kim Kelderman Director, Officer (Chief Executive Officer) | Shares withheld for tax | −10,821 | $72.40 | $783,440 |
| Jul 29, 2026 | Hippel James Officer (CFO) | Option exercise | +62,068 | $47.60 | $2,954,437 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.